Journal Home
Search for

Volume 42, Issue 8, Pages 578-584 (August 2010)


View previous. 12 of 17 View next.

Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis

Ilaria LenciaCorresponding Author Informationemail address, Fabio Marcuccillic, Giuseppe Tisoneb, Daniele Di Paoloa, Laura Tariciottib, Marco Ciottic, Tania Guencic, Carlo Federico Pernoc, Mario Angelicoa

Received 15 September 2009; accepted 6 December 2009. published online 25 January 2010.

Abstract 

Background

Life-long prophylaxis against HBV recurrence is recommended in patients transplanted for HBV-related disease. The risk of HBV reactivation is due to persistence of covalently closed circular (ccc) DNA in hepatocytes. Whether cccDNA persists in livers of long-term transplant survivors who received conventional prophylaxis is unknown.

Aim

To investigate the presence of intrahepatic total and cccDNA in transplanted patients with no evidence of biochemical markers of HBV recurrence.

Methods

Intrahepatic total and cccDNA were assessed using sensitive nested and real-time PCR from 44 HBsAg-positive patients (75% male; mean age 55.2±8.9 years) who had undetectable serum HBV-DNA at transplant. The mean follow-up after transplant was 88.3 months (range, 18–159).

Results

One patient underwent HBV recurrence after transplant and was the only who tested positive for both intrahepatic total HBV-DNA and cccDNA. Of the 43 patients negative for all serological markers of HBV infection, only 2 tested positive for intrahepatic total HBV-DNA, but none for cccDNA.

Conclusions

Most patients with undetectable HBV-DNA at transplant, who received conventional HBV prophylaxis, have no evidence of intrahepatic total HBV-DNA and cccDNA. cccDNA should be considered a new additional diagnostic tool, also to identify patients at low risk of HBV recurrence after liver transplantation.

a Hepatology Unit, Department of Internal Medicine, Tor Vergata University, Via Montpellier 1-00133 Rome, Italy

b Liver Transplant Unit, Tor Vergata Medical School, Rome, Italy

c Laboratory of Molecular Virology, Tor Vergata Medical School, Rome, Italy

Corresponding Author InformationCorresponding author at: Chair of Gastroenterology, Hepatology Unit, Department of Internal Medicine, Tor Vergata University, Via Montpellier 1-00133 Rome, Italy. Tel.: +39 06 72596803.

PII: S1590-8658(09)00469-1

doi:10.1016/j.dld.2009.12.003


View previous. 12 of 17 View next.